JCR Pharmaceuticals Co., Ltd. ( ) has issued an update. JCR Pharmaceuticals and Modalis Therapeutics have announced a progression to the next phase of their joint research agreeme ...

Recombinant human prourokinase is noninferior to alteplase and associated with decreased bleeding risks among patients with acute ischemic stroke, a new trial showed.

SMART-101 is under clinical development by Smart Immune and currently in Phase II for Relapsed Acute Myeloid Leukemia.

China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication ...

While cold air can affect anyone, it poses a greater risk to individuals with chronic lung diseases such as asthma or COPD ...

Introduction Acute exacerbation of interstitial lung disease (AE-ILD) often results in death and poses significant challenges ...

Sepsis, a severe and often fatal complication of infection, is a leading cause of both ALI and acute respiratory distress ...

China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication ...

The allogeneic bone marrow-derived mesenchymal stromal cell (MSC) therapy Ryoncil (remestemcel-L-rknd) has been approved for ...

Sepsis, a severe and often fatal complication of infection, is a leading cause of both acute lung injury (ALI) and acute ...

A cutting-edge study has identified medical ozone therapy as a promising new treatment for sepsis-induced acute lung injury ...